Terpenoid ID | TKC206750 | |
Chirality | TKC206177 | |
Cell line | 0 | |
Protein target | 8 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 0 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC206750 | P06276 | Cholinesterase | BCHE | 506 | ug.mL-1 | IC50 |
TKC206750 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 127 | % | Inhibition |
TKC206750 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 115 | % | Inhibition |
TKC206750 | Q9UNA4 | DNA polymerase iota | POLI | 28184 | nM | Potency |
TKC206750 | O75496 | Geminin | GMNN | 1413 | nM | Potency |
TKC206750 | O42275 | Acetylcholinesterase | ache | 3 | % | Inhibition |
TKC206750 | P81908 | Cholinesterase | BCHE | -3 | % | Inhibition |
TKC206750 | O00167 | Eyes absent homolog 2 | EYA2 | 17783 | nM | Potency |
TKC206750 | E5L6Y1 | 20-hydroxy-ecdysone receptor | 1047 | nM | IC50 | |
TKC206750 | P34021 | Ecdysone receptor | EcR | 46 | nM | IC50 |
TKC206750 | P34021 | Ecdysone receptor | EcR | 46 | nM | IC50 |
TKC206750 | Q4W6D0 | 20-hydroxy-ecdysone receptor | LdEcR-A | 437 | nM | IC50 |
TKC206750 | Q8MWR2 | 20-hydroxy-ecdysone receptor | EcR | 166 | nM | IC50 |
TKC206750 | O18531 | Ecdysone receptor | EcR | 5500 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P06276 | CHLE_HUMAN | Pain [ICD-11: MG30-MG3Z] |
P06276 | CHLE_HUMAN | Tonus and reflex abnormality [ICD-11: MB47] |
P06276 | CHLE_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P06276 | CHLE_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P06276 | CHLE_HUMAN | Eexposure to noxious substances harmful effect [ICD-11: NE61] |
P06276 | CHLE_HUMAN | Toxicity [ICD-11: N.A.] |
P06276 | CHLE_HUMAN | Unspecific substance harmful effect [ICD-11: NE6Z] |